Article
Hepatotoxicity from anabolic androgenic steroids marketed as dietary supplements: contribution from ATP8B1/ABCB11 mutations?
Liver international : official journal of the International Association for the Study of the Liver - 1 Sept 2013
El Sherrif Yasser, Potts Jonathan R, Howard Mark R, Barnardo Adrian, Cairns Stuart, Knisely Alex S, Verma Sumita
Abstract excerpt
BACKGROUND: Though possession of androgenic anabolic steroids (AAS) is illegal, non-prescription use of AAS persists. METHODS: We describe two Caucasian males (aged 25 and 45 years) with cholestatic hepatitis following ingestion of the dietary supplement Mass-Drol ('Celtic Dragon') containing the AAS 2α-17α-dimethyl-etiocholan-3-one,17β-ol. RESULTS: Despite substantial hyperbilirubinaemia peak gamma-glutamyl...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
